OXO bridged diazepan orexin receptor antagonists

Details for Australian Patent Application No. 2008255005 (hide)

Owner Merck & Co., Inc.

Inventors Whitman, David B.; Cox, Christopher D.

Agent Spruson & Ferguson

Pub. Number AU-A-2008255005

PCT Pub. Number WO2008/143856

Priority 60/930,927 18.05.07 US

Filing date 14 May 2008

Wipo publication date 27 November 2008

International Classifications

A01N 43/62 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

Event Publications

26 November 2009 PCT application entered the National Phase

  PCT publication WO2008/143856 Priority application(s): WO2008/143856

21 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

4 October 2012 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008255012-Wound and cutaneous injury healing with a nucleic acid encoding a proteoglycan polypeptide

2008255003-Lubrication for power utility connector